Abstract: The present invention provides novel polyurethane-based wound dressing foams, obtained by foaming and curing silane-terminated polyurethanes.

Abstract: The invention relates to a process for producing polyurethane foams, by frothing and drying mixtures of specific polyurethane dispersions and crosslinkers.

Abstract: The invention relates to a process for producing polyurethane foams, by frothing and drying mixtures of specific polyurethane dispersions and crosslinkers.

Abstract: The present invention describes microbicidal hydrophilic polyurethane foams endowed with polyhexamethylenebiguanide (PHMB) and/or its hydrochloride and also a superabsorbent, wound contact materials obtainable therefrom and processes for producing the therapeutically endowed polyurethane foams and the wound contact materials obtainable therefrom.

Abstract: The present invention relates to biomedical foam articles for the wound sector which are formed by spraying a polymeric dispersion onto a wound. The polymeric dispersion being sprayed onto a wound surface forms a three-dimensional body which conforms to the spatial shape of the wound and which, as well as covering the wound surface, ensures a complete and accurately fitted packing of the wound in the depth dimension as well as the other dimensions. The biomedical foam articles of the present invention are particularly useful for treating chronic wounds.

Abstract: The present invention describes microbicidal hydrophilic polyurethane foams endowed with polyhexamethylenebiguanide (PHMB) and/or its hydrochloride and also a superabsorbent, wound contact materials obtainable therefrom and processes for producing the therapeutically endowed polyurethane foams and the wound contact materials obtainable therefrom.

Abstract: This document provides methods and materials related to degradable biomolecule compositions. For example, methods and materials related to compositions having one or more biomolecules and one or more biomolecule degrading enzymes having activity to degrade the one or more biomolecules of the composition are provided. In some cases, the degradable biomolecule compositions provided herein can be used as wound dressings to facilitate wound healing, as tissue scaffolds or tissue matrices to promote tissue growth or tissue regeneration, as bulking agents to provide bulk to tissue in a temporary manner, and as non-medical devices to provide compositions that are degradable.

Abstract: The present invention describes microbicidal hydrophilic polyurethane foams endowed with polyhexamethylenebiguanide (PHMB) and/or its hydrochloride and also a superabsorbent, wound contact materials obtainable therefrom and processes for producing the therapeutically endowed polyurethane foams and the wound contact materials obtainable therefrom.

Abstract: The invention relates to a process for producing polyurethane foams for wound management wherein a composition containing a polyurethane dispersion and specific coagulants is frothed and dried.

Abstract: The invention relates to a process for producing polyurethane foams, by frothing and drying specific polyurethane dispersions.

Abstract: The present invention relates to biomedical foam articles for the wound sector which are formed by spraying a polymeric dispersion onto a wound. The polymeric dispersion being sprayed onto a wound surface forms a three-dimensional body which conforms to the spatial shape of the wound and which, as well as covering the wound surface, ensures a complete and accurately fitted packing of the wound in the depth dimension as well as the other dimensions. The biomedical foam articles of the present invention are particularly useful for treating chronic wounds.

Abstract: The present invention relates to biomedical foam articles for the wound sector which are formed by spraying a polymeric dispersion onto a wound. The polymeric dispersion being sprayed onto a wound surface forms a three-dimensional body which conforms to the spatial shape of the wound and which, as well as covering the wound surface, ensures a complete and accurately fitted packing of the wound in the depth dimension as well as the other dimensions. The biomedical foam articles of the present invention are particularly useful for treating chronic wounds.

Abstract: The invention relates to a process for producing polyurethane foams, by frothing and drying mixtures of specific polyurethane dispersions and crosslinkers.

Abstract: The invention relates to a process for producing polyurethane foams for wound management wherein a composition containing a polyurethane dispersion and inorganic, cationic coagulants is frothed and dried.

Abstract: The present invention provides novel polyurethane-based wound dressing foams, obtained by foaming and curing silane-terminated polyurethanes.

Abstract: The invention relates to a process for producing polyurethane foams for wound management. These polyurethane wound dressing foams are prepared by a process comprising frothing and drying of a foam foaming composition, which comprises a polyurethane dispersion and specific coagulants.

Abstract: The invention relates to a process for producing polyurethane wound dressing foams comprising frothing and drying polyurethane foam compositions which comprise anionically hydrophilicized aqueous polyurethane dispersions.

Abstract: The invention relates to benzofuranylsulfonates of the general formula (I), their preparation and their use for the treatment of inflammation.

Abstract: 3-Urea-pyridofurans and -pyridothiophenes are prepared by reacting appropriately substituted 3-amino-pyridofurans or -pyridothiophenes with isocyanates or isothiocyanates. The 3-urea-pyridofurans and -pyridothiophenes can be used as active ingredients in medicaments, particularly in medicaments for the treatment of acute and chronic inflammatory processes.

Abstract: The invention relates to the natural substance cyclamenol of the formula ##STR1## a process for its preparation from microorganisms of the order of the Actinomycetales, in particular from the Streptomyces strain MHW 846, chemical derivatives thereof, and its use as a medicament, in particular for acute and chronic inflammatory disorders in human and veterinary medicine.